-
Goldman Sachs Initiates MAKO Surgical At Buy, $36 PT
Tuesday, May 17, 2011 - 6:43am | 25Goldman Sachs has initiated coverage on MAKO Surgical (NASDAQ: MAKO) with a Buy rating and $36 price target.
-
Wunderlich Securities Reiterates Buy and PT of $18 on Abiomed (ABMD)
Tuesday, May 17, 2011 - 6:10am | 125Wunderlich Securities reiterated its price target on Abiomed (NASDAQ: ABMD). At the same time, Wunderlich left its rating unchanged at Buy. In a research report published today, Wunderlich stressed it remains very optimistic about Abiomed's long term outlook, citing high quality products and...
-
Overall Trend is Intact 05-16-2011
Monday, May 16, 2011 - 2:45pm | 997Cusick's Corner The EU is still bogging down stocks and technically the challenge has been made to the Bulls. At this juncture this does not mean it's a trend change. The overall trend to the upside is intact unless there are some larger headlines (i.e. EU debt or Retail getting hit). The...
-
Top Percentage Gainers and Losers as of 2:15pm 5/16/2011 (VITA, SYK, CISG, TISA, ENOC, TSTC, SPMD, KNDI, ABIO, KONG, OXGN, VRML, PSTR, FXCM, ATRN, SYMX, GSL)
Monday, May 16, 2011 - 2:15pm | 627Best 1) Orthovita (NASDAQ: VITA): Trading up 40.1% from Friday's close to $3.82. Orthovita is set to be acquired by Stryker (NYSE: SYK) for $3.85 per share in cash. The deal is valued at $316 million. 2) CNinsure (NASDAQ: CISG): Trading up 30.3% from Friday's close to $17.15. CNinsure received an...
-
Masimo Announces New Study Demonstrates the Accuracy of Noninvasive and Continuous Hemoglobin Monitoring in Patients in Surgery and Intensive Care
Monday, May 16, 2011 - 2:10pm | 93Masimo (NASDAQ: MASI) announced today that findings from a new study published in the American Journal of Surgery demonstrate that noninvasive and continuous hemoglobin monitoring correlates strongly with invasive laboratory hemoglobin testing and "can be beneficial in the operating room and...
-
Boston Scientific Announces Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in Treating Severe Asthma
Monday, May 16, 2011 - 12:45pm | 114Boston Scientific Corporation (NYSE: BSX) today announced long-term safety data from the Research in Severe Asthma Trial, which demonstrated the maintenance of stable lung function and the absence of clinical complications over a five-year period in patients with severe refractory asthma treated...
-
Biotech Stocks Research News Alert; Q1 Publishing Research Report on Verisante Technology, Inc.
Monday, May 16, 2011 - 11:21am | 2730May 16, 2011 - Investorideas.com newswire, a leader in investor stock research including biotech stocks, publishes the following Q1 Publishing Research Report on Verisante Technology, Inc. ( TSX-V: VRS) (PINK SHEETS: VRSEF). Q1 Publishing is an independent investment research firm which offers...
-
NASDAQ Stocks Hitting 52-Week Highs (TISA, VITA, ORCH, IPSU)
Monday, May 16, 2011 - 10:22am | 153Top Image Systems Ltd (NASDAQ: TISA) shares surged 33.17% to create a new 52-week high of $2.73. TISA reported that it has launched mobile banking solutions. Orthovita Inc (NASDAQ: VITA) shares jumped 40.11% to create a new 52-week high of $3.83. VITA agreed to be purchased by Stryker Corp (NYSE:...
-
Morning Market Movers (PRM, VITA, TISA, CISG)
Monday, May 16, 2011 - 9:50am | 142PRIMEDIA Inc (NYSE: PRM) jumped 60.50% to $7.03 at 9:50 am. PRM agreed to be purchased by TPG Capital (NASDAQ: TPCG) for $7.10 per share in cash. Orthovita Inc (NASDAQ: VITA) shares advanced 40.11% to $3.8250. VITA agreed to be purchased by Stryker Corp (NYSE: SYK) in a deal valued at $316 million...
-
Stocks to watch on 5/16/11- VITA, LOW, NDAQ, ICE, NYX, PRM, JCP, JOYG, IRM, TCG, DISH, RDC, NFLX, SYK…
Monday, May 16, 2011 - 9:15am | 1372Orthovita Inc. (VITA) agreed to be acquired by Stryker Corp. (SYK) for a $3.85 a share in cash in a deal valued at $316 million. Lowe's Cos. (LOW) estimated that for the fiscal second quarter ending July 29, it would earn 65 cents to 69 cents a share on 4% higher total sales and 2% higher same-...
-
Angeion Names Rob Wolf as CFO and Mark Gryzwa as VP of Engineering
Monday, May 16, 2011 - 9:04am | 98Angeion Corporation (NASDAQ: ANGN) today announced it has named Rob Wolf as chief financial officer and Mark Gryzwa as vice president of engineering, effective May 16, 2011. In their respective roles, Wolf and Gryzwa report to Angeion President and CEO Phil Smith. Wolf, 42, is responsible for...
-
Analogic Corporation Comments on Lawsuit Filed by NeuroLogica
Monday, May 16, 2011 - 8:42am | 117Analogic Corporation (Nasdaq: ALOG) today commented on a lawsuit filed on Friday, May 13 in the United States District Court, District of Massachusetts, by NeuroLogica Corporation and senior officers of that company. Recently, information came to Analogic's attention that its intellectual property...
-
Stryker To Acquire Orthovita For $316 million
Monday, May 16, 2011 - 8:28am | 72Orthovita Inc (NASDAQ: VITA) agreed to be purchased by Stryker Corp (NYSE: SYK) in a deal valued at $316 million. The purchase price of $3.85 per share in cash represents a 41% premium over VITA's closing price of $2.73 per share on Friday. VITA shares fell 1.09% to close at $2.73 on Friday,...
-
Orthovita, Inc. Agrees To Be Acquired by Stryker Corporation for $3.85 Per Share in Cash
Monday, May 16, 2011 - 8:00am | 60Orthovita, Inc. (Nasdaq: VITA) today announced that it has entered into a merger agreement under which Stryker Corporation (NYSE: SYK) has agreed to acquire all of the common stock of Orthovita for $3.85 per share in cash which represents a total value of approximately $316 million.
-
Deutsche Bank Reports on Mindray Medical, China Medical Technologies (MR, CMED)
Monday, May 16, 2011 - 7:54am | 211In a report released today, Deutsche Bank commented on Mindray Medical (NYSE: MR) and China Medical Technologies (NASDAQ: CMED). In the report, Deutsche Bank was positive in its outlook for the companies in terms of their potential growth in the Chinese economy. Deutsche Bank writes, “[Chinese]...